# Alaunos Therapeutics, Inc.: Form SCHEDULE 13D, filed Jul 1, 2025

- Company: [Alaunos Therapeutics, Inc.](/companies/tcrt.md) (CIK 1107421)
- Form: SCHEDULE 13D
- Filed: 2025-07-01
- Accepted by EDGAR: Jul 1, 2025, 23:40 ET
- Period: not reported
- Accession: 0000921895-25-001912
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1107421/000092189525001912/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1107421/000092189525001912/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1107421/000092189525001912/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jul 1, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-001912. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.